Quince Therapeutics, Inc. - QNCX

Sector: Healthcare · Industry: Biotechnology

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$8.604M

QoQ value delta ($000)

-$59.22M (-87.31%)

Implied price effect (QoQ)

-85.25%

Total shares

17,418,777

QoQ shares delta

-2,835,526 (-14.0%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 48 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
VANGUARD GROUP INC	6,981	2,084,015	0.0%
Woodline Partners LP	527	5,200,000	0.0%
MILLENNIUM MANAGEMENT LLC	253	2,503,717	0.0%
Shay Capital LLC	179	1,772,909	0.01%
ACADIAN ASSET MANAGEMENT LLC	176	1,750,862	0.0%
TWO SIGMA ADVISERS, LP	90	27,100	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	79	796,140	0.0%
IEQ CAPITAL, LLC	60	600,105	0.0%
BlackRock, Inc.	47	473,259	0.0%
VANGUARD CAPITAL MANAGEMENT LLC	46	461,477	0.0%
STATE STREET CORP	25	248,011	0.0%
VANGUARD FIDUCIARY TRUST CO	23	232,326	0.0%
TUDOR INVESTMENT CORP ET AL	22	220,000	0.0%
CITADEL ADVISORS LLC	17	168,500	0.0%
SIMPLEX TRADING, LLC	15	154,093	0.0%
Vanguard Personalized Indexing Management, LLC	13	132,661	0.0%
ADAR1 Capital Management, LLC	10	100,100	0.0%
TWO SIGMA INVESTMENTS, LP	7	71,223	0.0%
NORTHERN TRUST CORP	6	65,931	0.0%
Intellectus Partners, LLC	5	53,312	0.0%
XTX Topco Ltd	4	48,812	0.0%
Catalyst Funds Management Pty Ltd	3	30,000	0.0%
Gen-Wealth Partners Inc	3	33,018	0.0%
Cambridge Investment Research Advisors, Inc.	2	15,200	0.0%
Nordwand Advisors, LLC	2	20,000	0.0%